Chimeric antigen receptor T-cell as a significant player in the innovative treatment of hematological cancers
Introduction and purpose: Chimeric antigen receptor‐T (CAR‐T) cells have achieved inspiring outcomes in the treatment for lymphoid malignancies, especially diffuse large B-cell lymphoma (DLBCL) and acute lymphoblastic leukemia (ALL), providing alternative therapeutic options for patients who failed...
Saved in:
Main Authors: | Karolina Makowska (Author), Kinga Panuciak (Author), Angelika Mastalerczyk (Author), Emilia Nowicka (Author), Michał Obel (Author), Kamila Czyżak (Author), Jan Lejman (Author), Natalia Trąbka (Author), Klaudia Jedlina (Author), Katarzyna Pacek (Author) |
---|---|
Format: | Book |
Published: |
Kazimierz Wielki University,
2023-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Poly ADP-ribose polymerase (PARP) inhibitors - new therapeutic strategies in Acute Myeloid Leukemia: a literature review
by: Emilia Nowicka, et al.
Published: (2022) -
Congenital myasthenic syndromes (CMS) a rare cause of uncommon fatigue
by: Jan Lejman, et al.
Published: (2022) -
Abscesses and cysts of Bartholin's gland - contemporary problems of active women
by: Kinga Panuciak, et al.
Published: (2022) -
Chimeric Antigen Receptor-T-Cell Therapy for B-Cell Hematological Malignancies: An Update of the Pivotal Clinical Trial Data
by: Gils Roex, et al.
Published: (2020) -
Idiopathic pulmonary fibrosis - novel approach on future treatment
by: Katarzyna Pacek, et al.
Published: (2023)